Overexpression of SEMA3C was identified to promote proliferation, migration, and invasion of tumor cells; thus, it will provide a potential biomarker for diagnosis, prognosis, and personalized medicine in TSCC. This evidence concerns the gene SEMA3C and neoplasm.